ArticlePloS one2026

A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia.

Chala Kenenisa Edae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.